Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action.
Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action.
复制标题
DOI:
10.1523/jneurosci.2156-12.2012
复制
发表时间:
2012-10-10
期刊:
影响因子:
--
通讯作者:
West AE
中科院分区:
文献类型:
--
作者:
Hutchinson AN;Deng JV;Cohen S;West AE
Although tricyclic antidepressants rapidly activate monoaminergic neurotransmission, these drugs must be administered chronically to alleviate symptoms of depression. This observation suggests that molecular mechanisms downstream of monoamine receptor activation, which include the induction of gene transcription, underlie chronic antidepressant-induced changes in behavior. Here we show that methyl-CpG binding protein 2 (MeCP2) regulates behavioral responses to chronic antidepressant treatment. Imipramine administration induces phosphorylation of MeCP2 at Ser421 (pMeCP2) selectively in the nucleus accumbens and the lateral habenula, two brain regions important for depressive-like behaviors. To test the role of pMeCP2 in depressive-like behaviors, we utilized male mice that bear a germline mutation knocked into the X-linked Mecp2 locus that changes Ser421 to a nonphosphorylatable Ala residue (S421A). MeCP2 S421A knockin (KI) mice showed increased immobility in forced swim and tail suspension tests compared with their wildtype (WT) littermates. However immobility of both MeCP2 WT and KI mice in forced swim was reduced by acute administration of imipramine, demonstrating that loss of pMeCP2 does not impair acute pharmacological sensitivity to this drug. Following chronic social defeat stress, chronic administration of imipramine significantly improved social interaction in the MeCP2 WT mice. By contrast, the MeCP2 KI mice did not respond to chronic imipramine administration. These data suggest novel roles for pMeCP2 in the sensitivity to stressful stimuli and demonstrate that pMeCP2 is required for the effects of chronic imipramine on depressive-like behaviors induced by chronic social defeat stress.